AI system allows accurate retinopathy diagnosis by non-ophthalmologists
New research demonstrates that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy in more than 95% of cases. The system can be used by non-ophthalmologists and provides readings in 60 seconds.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>